Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: RE: Good morning,

RE: Good morning,

posted on Oct 17, 2005 07:07AM
``Does anyone think there is still anything to the possibility that they are using PTSC as a shell in order to become a public company`

I was thinking along these lines this weekend and briefly I these are some of the positives and negatives to that scenario.

Positives

1) Consolidates MMP

2) Consolidates Shboom (if Shboom is basis of the new chip)

3) Is, as you say, a short cut method of TPLs becoming publicly listed.

Negatives

PTSC`s outstanding liabilties

1) Management history

2) B & O case against PTSC is unresolved

3) Outstanding debentures

It would limit TPL access to the big IPO $$$.

A buyout/merger would explain things like Pohl`s silence and Sweeney`s temporary status. But I think the market it broadcasting the likelyhood of that scenario.

Share
New Message
Please login to post a reply